Invest in

Fighting Fat

9.0%
9.0%
0.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
9.0%
9.0%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
57.9% Diabetes Care 4.6%
19.9% Novo Nordisk A/S NVO 2.4%
16.0% Merck & Company Inc. (new) MRK 6.3%
15.1% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 17.6%
2.9% Astrazeneca Plc ADR AZN 0.4%
2.1% Alkermes plc ALKS 25.1%
1.8% Integer Holdings Corporation ITGR --
35.0% Weight Management 28.6%
13.5% NutriSystem Inc NTRI 4.9%
7.5% MEDIFAST INC MED 15.0%
3.9% Weight Watchers International Inc WTW 196.1%
3.6% Nu Skin Enterprises Inc. (A) NUS 39.8%
2.3% GNC Holdings Inc. Class A GNC 32.9%
2.1% USANA Health Sciences Inc. USNA 2.3%
2.1% Vitamin Shoppe Inc VSI 9.3%
7.1% Weight Loss Drugs 58.4%
7.1% Arena Pharmaceuticals Inc. ARNA 58.4%

Quotes delayed 15 mins. Currently Jul 27, 2016 9:27:11 AM. Fields are marked with -- when data is unavailable.